INTERNATIONAL PATENT: PRELUDE THERAPEUTICS INCORPORATED FILES APPLICATION FOR "COMBINATION TREATMENT REGIMENS - SMARCA2 DEGRADER WITH TAXANE ANTICANCER AGENT"

GENEVA, Sept. 22 -- PRELUDE THERAPEUTICS INCORPORATED (175 Innovation BoulevardWilmington, Delaware 19805) filed a patent application (PCT/US2025/019966) for "COMBINATION TREATMENT REGIMENS - SMARCA2 DEGRADER WITH TAXANE ANTICANCER AGENT" on Mar 14, 2025. With publication no. WO/2025/194059, the details related to the patent application was published on Sep 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ITO, Koichi (175 Innovation BoulevardWilmington, Delaware 19805), HULSE, Michael (175 Innovation BoulevardWilmington, Delaware 19805), SCHERLE, Peggy (175 Innovation BoulevardWilmington,...